Identification and delivery of clinical drug candidates
Ended Awarded Last action
- Contract number
- HHSN26100034
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $5,506,164
Award facts
- Opportunity
-
- N01CO5240180 Solicitation number
- Operations and Technical Support for the Frederick National Laboratory for Cancer Research (FLNCR), a Federally Funded Research and Development Center (FFRDC) Award Notice · Posted Apr 27, 2015
- Contract value 100% obligated
- $5,506,164.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 561210 Facilities Support Services
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Cost No Fee
- Place of performance
- Frederick, MD 21702, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $77,717 | |
| Other Administrative Action | $0 | |
| Original award | $5,428,447 |
About this award
This is a federal contract award made by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. The contract, valued at $5,506,164.00, is for the identification and delivery of clinical drug candidates. It is a delivery order contract, with a cost-no-fee pricing type.
The contract is not set aside and is part of Leidos Biomedical Research's role as a Federally Funded Research and Development Center (FFRDC) contractor for the NCI. As an FFRDC, Leidos Biomedical Research provides a broad range of biomedical research, development, and production services to the NCI, including facilities operations and maintenance, clinical trials management, and specialized laboratory testing. This contract award is part of Leidos Biomedical Research's larger single-award Indefinite Delivery Contract from the NCI, valued at up to $6.6 billion over 5 years, to deliver a wide range of services through individual task orders.
Quick answers
Who was awarded contract HHSN26100034?
HHSN26100034 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on September 19, 2016.
How much is contract HHSN26100034 worth?
The government has obligated $5,506,164 on HHSN26100034.
Is contract HHSN26100034 an order under another contract?
Yes. HHSN26100034 is a delivery order under HHSN261201500003I, an indefinite delivery contract.
Was contract HHSN26100034 competed?
The extent of competition for HHSN26100034 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award